Communicating with patients with nAMD and their families during the COVID-19 pandemic

Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1335-1337. doi: 10.1007/s00417-020-04697-6. Epub 2020 Apr 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • Bevacizumab
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Intravitreal Injections
  • Pandemics*
  • Pneumonia, Viral
  • SARS-CoV-2

Substances

  • Bevacizumab